Community/Retail

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

David Pope, PharmD, CDE, and chief innovation officer of OmniSYS, and John King, CEO of OmniSYS, discuss some opportunities to leverage cash prescriptions to drive revenue in the pharmacy.

The Phase III ETHOS trial for AstraZeneca's budesonide, glycopyrronium and formoterol fumarate, 320/14.4/9.6mcg (Breztri Aerosphere) combination therapy has demonstrated positive results for patients with moderate to severe chronic obstructive pulmonary disease (COPD).

Pharmacists can assist with advising patients who present with quality concerns to use CBD products that provide certificates of analyses, and catch significant drug interactions before they occur.

Jim Kirby, PharmD, BCPS, CDE, and senior director of pharmacy services for The Kroger Co., discusses why preventive care services are necessary in pharmacy practice.

Researchers at Weill Cornell Medicine have found that states requiring prescribers and dispensers to register with and use prescription drug monitoring programs saw significantly fewer opioid prescriptions and reduced opioid-related hospital use, when compared to states with weak drug monitoring program mandates.

These funds are earmarked for the expansion of access to treatment and to support near real-time data on drug overdoses.

Julie Johnson, Dean of the University of Florida College of Pharmacy, on standards of education for pharmacy students around pharmacogenetics and pharmacogenomics.

A federal court has ordered 2 Tennessee-based companies with the same owner to stop disstributing drugs, dietary supplements, and devices until they are found to be in compliance with the Federal Food, Drug, and Cosmetic (FD&C) Act and other requirements.

Pharmacy Times has announced the addition of the Society of Infectious Diseases Pharmacists (SIDP) to its Strategic Alliance Partnership (SAP) program.

David Pope, PharmD, CDE, chief innovation officer of OmniSYS, and John King, CEO of OmniSYS, discuss how they're tackling medication adherence concerns and how technology can provide a solution. This video was filmed at the 2019 NACDS Total Store Expo.

Community Pharmacy Consultant Bruce Kneeland and Theresa Dickinson, RPh, owner of Melrose Pharmacy in Phoenix, AZ, discusses direct payment options for payers and patients.

The gel product, which was first approved by the FDA in 2013, is intended for cheek augmentation to correct age-related volume deficit in the mid-face in adults over age 21 years.

Jim Kirby, PharmD, BCPS, CDE, and senior director of pharmacy services for The Kroger Co., discusses how chain pharmacies have a unique opportunity in preventive care services.

What is causing the oliguria in this normally healthy young man with a history of acne and a current sinus infection?

Patricia Kienle, BSPHARM, MPA, FASHP, discusses recent revisions to USP 797 and how pharmacists' comments can influence future revisions.

The antivaccination movement has been a driving force in the global measles outbreaks, and dissemination of inaccurate information has contributed to the growing problem.

Julie Johnson, Dean of the University of Florida College of Pharmacy, on the ways pharmacogenetics can be utilized for mental health.

Community Pharmacy Consultant Bruce Kneeland and Theresa Dickinson, RPh, owner of Melrose Pharmacy in Phoenix, AZ, discusses compounding at the Melrose Pharmacy.

In recent years, health care professionals have been seeing a surge in adverse effects associated with long-term use of antibiotics, as well as abuse, not only in the United States, but around the world.

David Pope, PharmD, CDE, and John King, CEO of OmniSYS, discuss how new opportunities for pharmacies are also creating new questions and needs.

As the industry moves toward a more patient-centric model, pharmacy schools like Touro are implementing programs to ensure their students are prepared for every aspect of their career—including physical exams.

Recently published in Science Daily, the study was based on the investigating team’s analysis of more than 12 million reports from the FDA Adverse Effect Reporting System (FAERS) and Adverse Event Reporting System (AERS) databases.

Patricia Kienle, BSPHARM, MPA, FASHP, talks about on the appropriate facilities in which to perform sterile compounding in this video, filmed during the 2019 American Society of Health-System Pharmacists (ASHP) Summer Meetings & Exhibition in Boston.

A randomized clinical trial found that among patients with psychotic depression in remission, continuing sertraline plus olanzapine reduced the risk of relapse over 36 weeks when compared with sertraline plus a placebo.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Jim Kirby, PharmD, BCPS, CDE, and Sr. Director of Pharmacy Services for The Kroger Co., discusses his recommendations for implementing or expanding preventive care services in your pharmacy.

August is National Immunization Awareness Month, and pharmacists can play a key role in ensuring that this age group remains fully vaccinated against preventable diseases that may impact their lives.